17.12.2015 07:14:41

UBS Completes Public Tender Offer - Quick Facts

(RTTNews) - UBS (UBS) announces the successful completion of the cash tender offers, announced on 4 December 2015, to re-purchase 17 issues of its senior, subordinated debt and covered bonds with an aggregate principal amount equivalent to approximately CHF 16 billion. 14 securities with an aggregate principal amount equivalent to approximately CHF 6.1 billion were accepted.

The company expects to record an expense in the fourth quarter of 2015 related to this transaction of approximately CHF 272 million, which will be recognized as negative other income within Corporate Center - Group Asset and Liability Management and will be treated as an adjusting item in determining the Group's adjusted operating profit/ (loss) before tax.

It expects to recover the expense incurred in approximately 1.6 years primarily through reduction of future interest expense from the purchased bonds.

The repurchase of the bonds is expected to have an immaterial effect on the company's CET1 ratio, however the transaction will reduce our BIS Basel III phase-in total capital by approximately CHF 658 million.

Some of the subordinated bonds repurchased are currently eligible as Tier 2 under the BIS Basel III phase-in rules, but will not be eligible for Tier 2 capital treatment on a fully-applied basis beginning in 2019 and are not expected to be eligible as loss absorbing capacity under the anticipated revisions to the Swiss "too-big-to-fail" regulation.

Analysen zu UBSmehr Analysen

13.01.25 UBS Overweight JP Morgan Chase & Co.
08.01.25 UBS Hold Deutsche Bank AG
06.01.25 UBS Outperform RBC Capital Markets
27.12.24 UBS Outperform RBC Capital Markets
06.12.24 UBS Overweight JP Morgan Chase & Co.
Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

UBS 10,46 -0,48% UBS